Partner with Viritis
Viritis is developing a next-generation antiviral discovery platform designed to generate therapeutic candidates against emerging viral threats.
We welcome inquiries from pharmaceutical companies, investors, and research partners interested in collaboration, strategic partnerships, or investment opportunities.
Business Development & Partnerships
For pharmaceutical companies and strategic collaborators interested in antiviral programs or platform partnerships.
Investor Inquiries
For investors interested in learning more about Viritis platform and pipeline.
Scientific Collaboration
For academic researchers and institutions interested in joint research.
General Queries
Join Us in Advancing Antiviral Therapeutics
Viritis is building a scalable platform for antiviral drug development and is actively seeking strategic collaborations with pharmaceutical partners and investors.